EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE
Objective: to evaluate the clinical efficacy and safety of the targeted synthetic disease-modifying anti-rheumatic drug (DMARD) tofacitinib (TOFA; Yakvinus®) in patients with active psoriatic arthritis (PsA) at 12 and 24 weeks after starting treatment. To define the place of TOFA in the therapy of P...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Russo |
| Wydane: |
IMA PRESS LLC
2020-06-01
|
| Seria: | Научно-практическая ревматология |
| Hasła przedmiotowe: | |
| Dostęp online: | https://rsp.mediar-press.net/rsp/article/view/2892 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|